Gilead’s quarterly loss is narrower than expected

Gilead Sciences Inc.’s stock rose 0.8% in after-hours trading Thursday, after the drug company’s adjusted first-quarter profit was narrower than expected.

Previous post Snap shares rocket more than 20% higher on brighter second-quarter forecast
Next post Alphabet’s stock surges on Triple Crown of first-ever cash dividend, $70 billion stock buyback, strong results